News about Manufacturing

A New Year, A New Chapter for Pharma Manufacturing in India

As India steps into a new year, the pharmaceutical manufacturing sector stands at a defining crossroads. Over the past few years, Indian pharma has moved far beyond its traditional identity as the “pharmacy of the world” for generics.

Manufacturing | 01/01/2026 | By Darshana

Corona Remedies to Expand Bhayla Manufacturing Capacity by 400 Million Units

Corona Remedies Limited has announced an expansion of manufacturing capacity at its Bhayla formulation facility to support rising demand for its products. The expansion will add 400 million units of tablet and capsule capacity, with 240 million units expected to be available for utilisation.

Manufacturing | 29/12/2025 | By Darshana

Kashiv BioSciences Secures INR 684 Crore to Build Biopharma Facility

Kashiv BioSciences has secured INR 648 crore in financing from Union Bank of India to invest in a state-of-the-art biologics manufacturing facility in Pipan, Gujarat, aimed at strengthening technical capabilities, enhancing global competitiveness, and generating long-term, high-value employment across scientific, technical and operational roles.

Manufacturing | 26/12/2025 | By News Bureau

Pluri and Remedy Cell Expand Partnership with Clinical-Grade Manufacturing Success

The duo have integrated Remedy Cell’s proprietary manufacturing process into Pluri’s GMP facility, completed GMP training and qualification for Remedy Cell’s manufacturing team, conducted engineering runs to validate process robustness and scalability, and produced multiple clinical-grade batches of Remedy Cell's lead candidate.

Manufacturing | 23/12/2025 | By News Bureau

TempraMed Opens New Florida Manufacturing Facility to Boost Output and Cut Costs

TempraMed Technologies Ltd, a medical technology company focused on improving the storage and management of temperature-sensitive medications, has opened an additional manufacturing facility in Florida, strengthening its production footprint in the United States.

Manufacturing | 19/12/2025 | By Darshana

US FDA Places Sun Pharma's Baska Facility Under 'Official Action Indicated' After Inspection

Sun Pharmaceutical Industries Ltd said the U.S. Food and Drug Administration (FDA) has assigned an “Official Action Indicated” (OAI) status to its Baska manufacturing facility following a recent regulatory inspection.

Manufacturing | 18/12/2025 | By Darshana |  101

US FDA Issues EIR with VAI Classification to Lupin's Nagpur Injectables Plant

Global pharmaceutical major Lupin Limited (Lupin) has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its injectable manufacturing facility located in Nagpur, India.

Manufacturing | 17/12/2025 | By Darshana

TempraMed Secures South Korea Patent for VIVI Box Medication Storage Technology

TempraMed Technologies Ltd, a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, announced that it has been granted an additional allowed patent in South Korea, issued under Korean Patent Application No. 10-2021-7011422.

Manufacturing | 17/12/2025 | By Darshana

EU Approves AstraZeneca's Saphnelo for Subcutaneous Self-Administration in Lupus

AstraZeneca has received approval from the European Commission for subcutaneous self-administration of Saphnelo (anifrolumab) using a pre-filled pen for adult patients with systemic lupus erythematosus, in addition to standard therapy.

Manufacturing | 17/12/2025 | By Darshana

PharmAla Biotech Australia Ties Up with UK CDMO to Manufacture ALA-002

PharmAla Biotech Australia has contracted a UK-based CDMO to manufacture the drug substance for ALA-002, its patented non-racemic MDMA formulation, ahead of planned phase 2a/2b clinical trials for social anxiety disorder expected to begin in 2026.

Manufacturing | 16/12/2025 | By News Bureau